| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |